Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4966959 | 0.87 | CYP2A6 (0.55) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL10105480 | 0.83 | CYP2A6 (0.55) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL663629 | 0.81 | CYP2A6 (0.61) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL7371792 | 0.79 | CYP2A6 (0.55) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL7271231 | 0.79 | CYP2A6 (0.55) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL219866 | 0.79 | CYP2A6 (0.64) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL28181946 | 0.79 | CYP2A6 (0.69) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL2458423 | 0.79 | CYP2A6 (0.69) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL2458425 | 0.79 | CYP2A6 (0.69) | CYP2A6MAPTKDM4EIDO1NPSR1 | |
| SCHEMBL31448047 | 0.76 | CYP2A6 (0.60) | CYP2A6MAPTKDM4EIDO1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116554109-A | Inhibitors of bruton's tyrosine kinase and methods of preparing the same | 中山大学 | 2023-08-08 | — | — | CN | claimed |
| US-8450525-B2 | Histone deacetylase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-05-28 | — | — | US | claimed |
| US-20100298402-A1 | STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2010-11-25 | — | — | US | claimed |
| US-20100291003-A1 | HISTONE DEACETYLASE INHIBITORS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2010-11-18 | — | — | US | claimed |
| EP-2209765-A2 | HISTONE DEACETYLASE INHIBITORS | Orchid Research Laboratories Limited (IN) | 2010-07-28 | — | — | EP | claimed |
| WO-2009060282-A2 | STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2009-05-14 | — | — | WO | claimed |
| WO-2009053808-A2 | HISTONE DEACETYLASE INHIBITORS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2009-04-30 | — | — | WO | claimed |
| EP-1773780-A4 | AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | INCYTE CORP (US) | 2008-01-09 | — | — | EP | claimed |
| EP-1773780-A2 | AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | Incyte Corporation (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2006012227-A2 | AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | INCYTE CORPORATION (US) | 2006-02-02 | — | — | WO | claimed |
| US-20050288338-A1 | Amido compounds and their use as pharmaceuticals | INCYTE CORPORATION | 2005-12-29 | — | — | US | claimed |
| US-6391917-B1 | ANALGESIC | ZYMOGENETICS, INC. | 2002-05-21 | — | — | US | claimed |
| US-6255351-B1 | TREATMENT OF BONE DISORDERS | ZYMOGENETICS, INC. | 2001-07-03 | — | — | US | claimed |
| US-6221913-B1 | Dialkyl ureas as calcitonin mimetics | ZYMOGENETICS, INC. | 2001-04-24 | — | — | US | claimed |
| EP-0975589-A2 | DIALKYL UREAS AS CALCITONIN MIMETICS | ZymoGenetics, Inc. (US) | 2000-02-02 | — | — | EP | claimed |
| WO-1999037604-A2 | DIALKYL UREAS AS CALCITONIN MIMETICS | ZYMOGENETICS, INC. (US) | 1999-07-29 | — | — | WO | claimed |
| US-5801183-A | HETEROCYCLC ALCOHOLS FOR NERVOUS SYSTEM DISORDERS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1998-09-01 | — | — | US | claimed |
| US-5268378-A | Oxo group in 2 and 4 position | MERCK SHARP & DOHME, LIMITED (GB) | 1993-12-07 | — | — | US | claimed |
| US-20240239805-A1 | AZA-YANG CYCLIZATION-BUCHNER AROMATIC RING EXPANSION: COLLECTIVE SYNTHESIS OF CYCLOHEPTATRIENE-CONTAINING AZETIDINE LACTONES | UNIVERSITY OF KANSAS | 2024-07-18 | — | — | US | disclosed |
| US-4076703-A | 2-O-CHLOROBENZOYL-4-CHLORO-N-METHYL-N(ALPHA)-GLYCYL-GLYCINANILIDE | SHIONOGI & CO., LTD. (JA) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239805-A1 | AZA-YANG CYCLIZATION-BUCHNER AROMATIC RING EXPANSION: COLLECTIVE SYNTHESIS OF CYCLOHEPTATRIENE-CONTAINING AZETIDINE LACTONES | AZI2, NISCH, TET2 | CYP2A6 199/4885MAPT 3999/4885KDM4E 159/4885 |
| US-20100291003-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC11, HDAC5 | CYP2A6 1021/4885MAPT 41/4885KDM4E 453/4885 |
| US-20100298402-A1 | STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS | IL6, IL6ST, STAT3 | CYP2A6 102/4885MAPT 108/4885KDM4E 3876/4885 |
| US-20050288338-A1 | Amido compounds and their use as pharmaceuticals | HSD11B1, CYP11B1, HSD11B2 | CYP2A6 264/4885MAPT 3691/4885KDM4E 3590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.